Michael Ropacki

Amarantus Bioscience appointed Michael Ropacki as chief medical advisor to its alzheimer's blood diagnostic LymPro test program. Ropacki will be responsible for helping oversee the further development of LymPro. He will also assist a management team currently being recruited to lead the firm's neurodiagnostics division in raising capital for a neurodiagnostics subsidiary that it will soon establish. Amarantus noted that Ropacki brings more than 20 years of clinical development experience as a clinical leader, investigator, and consultant.